Skip to main content
SpringerLink
Log in

Relationship between Hodgkin’s and non-Hodgkin’s lymphomas

  • Review
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Malignant lymphomas have traditionally been classified as either Hodgkin’s (HL) or non-Hodgkin’s lymphomas (NHL). The tumor cells in NHL have been identified as being derived from T- or B-lymphocytes, but not until recently was it possible to identify the origin of the tumor cells in HL. Differential diagnostic problems may exist with morphological overlaps between HL and NHL but do not reflect an underlying biological relationship. Recent observations indicate that HL and NHL may be more closely related than previously believed. HL and NHL may occur sequentially or simultaneously in one and the same individual and in a few cases a clonal relationship between the lymphomas has been proven. It is thus possible that a biological relationship between the disorders may exist in addition to morphological overlaps, and the purpose with this review is to summarize the different relations between HL and NHL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harris, N.L., et al. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361–1392.

    PubMed  CAS  Google Scholar 

  2. Jaffe, E.S. and Mueller-Hermelink, K. (1999). Relationship between Hodgkin’s disease and non-Hodgkin’s lymphomas, in Hodgkin’s Disease (P.M. Mauch, et al., eds), pp181–193, Lippincott Williams & Wilkins, Philadelphia.

    Google Scholar 

  3. Küppers, R., et al. (1994). Hodgkin’s disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. 91:10,962–10,966.

    Article  Google Scholar 

  4. Kanzler, H., Küppers, R., Hansmann, M.L. and Rajewsky, K. (1996). Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1495–1504.

    Article  PubMed  CAS  Google Scholar 

  5. Bennet, M.H., MacLennan, K.A., Vaughan Hudson, G. and Vaughan Hudson, B. (1991). Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: a 20 year experience. Ann. Oncol. 2:83–92.

    Google Scholar 

  6. Henry-Amar, M. (1992). Second cancer after treatment for Hodgkin’s disease: a report from the international database on Hodgkin’s disease. Ann. Oncol. 3:117–128.

    PubMed  Google Scholar 

  7. Henry-Amar, M. and Joly, F. (1996). Late complications after Hodgkin’s disease. Ann. Oncol. 7:115–126.

    PubMed  Google Scholar 

  8. Rüffer, U., et al. (2001). Non-Hodgkin’s lymphoma after primary Hodgkin’s disease the German Hodgkin’s Lymphoma Study Group: incidence, treatment and prognosis. J. Clin. Oncol. 19(7):2026–2032.

    Google Scholar 

  9. Dores, G.M., et al. (2002). Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. J. Clin. Oncol. 20:3484–3494.

    Article  PubMed  Google Scholar 

  10. Travis, L.B., Gonzales, C.L., Hankey, B.F. and Jaffe, E.S. (1992). Hodgkin’s disease following non-Hodgkin’s lymphoma. Cancer 69:2337–2342.

    Article  PubMed  CAS  Google Scholar 

  11. Jaffe, E.S., Zarate-Osorno, A., Kingma, D.W., Raffeld, M. and Medeiros, L.J. (1994). The interrelationship between Hodgkin’s disease and non-Hodgkin’s lymphoma. Ann. Oncol. 5:7–11.

    PubMed  Google Scholar 

  12. Amini, R.-M., Enblad, G., Sundström, C. and Glimelius, B. (1997). Patients suffering from both Hodgkin’s disease and non-Hodgkin’s lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int. J. Cancer 71:510–516.

    Article  PubMed  CAS  Google Scholar 

  13. Merk, K., et al. (1990). Epidemiological study of Hodgkin’s disease in Cuba and Sweden. Oncology 47:246–250.

    Article  PubMed  CAS  Google Scholar 

  14. Hartge, P., Devesa, S.S. and Fraumeni, J.F., Jr. (1994). Hodgkin’s and non-Hodgkin’s lymphomas. Cancer Surv. 19–20:423–453.

    PubMed  Google Scholar 

  15. Foss Abrahamsen, A., et al. (1997). Hodgkin’s disease in a national and hospital population: trends over 20 years. Eur. J. Cancer 33:2380–2383.

    Article  PubMed  CAS  Google Scholar 

  16. Liu, S., Semenciw, R., Waters, C., Wen, S.W. and Mao, Y. (2000). Time trends and sex patterns in Hodgkin’s disease incidence in Canada, 1970–1995. Can. J. Public Health 91:188–192.

    PubMed  CAS  Google Scholar 

  17. Hjalgrim, H., et al. (2001). Incidence of Hodgkin’s disease in Nordic countries. Lancet 358:297–298.

    Article  PubMed  CAS  Google Scholar 

  18. Seow, A., Lee, J., Sng, I., Fong, C.M. and Lee, H.P. (1996). Non-Hodgkin’s lymphoma in an Asian population: 1968–1992: time trends and ethnic differences in Singapore. Cancer 77:1899–1904.

    Article  PubMed  CAS  Google Scholar 

  19. Seitz, V., et al. (2000). Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin’s disease. Blood 95:3020–3024.

    PubMed  CAS  Google Scholar 

  20. Müschen, M., et al. (1991). Rare occurrence of classical Hodgkin’s disease as a T cell lymphoma. J. Exp. Med. 191:387–394.

    Article  Google Scholar 

  21. Marafioti, T., et al. (2000). Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95:1443–1450.

    PubMed  CAS  Google Scholar 

  22. Stein, H., et al. (2001). Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97:496–501.

    Article  PubMed  CAS  Google Scholar 

  23. Lam, K.P., Kuhn, R. and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on mature B cells by inducable gene targeting results in rapid cell death. Cell 90:1073–1083.

    Article  PubMed  CAS  Google Scholar 

  24. Gruss, H.-J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997). Hodgkin’s disease: a tumor with disturbed immunological pathways. Immunol. Today 4:156–163.

    Article  Google Scholar 

  25. Kadin, M.E. and Liebowitz, D.N. (1999). Cytokines and cytokine receptors in Hodgkin’s Disease, in Hodgkin’s Disease (Mauch, P.M., et al., eds), pp139–157, Lippincott Williams & Wilkins, Philadelphia.

    Google Scholar 

  26. Poppema, S. and van den Berg, A. (2000). Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas. Semin. Cancer Biol. 10:345–350.

    Article  PubMed  CAS  Google Scholar 

  27. Hsu, P.-L. and Hsu, S.-M. (2000). Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin’s disease and anaplastic large cell lymphoma. Lab. Invest. 80:1111–1119.

    PubMed  CAS  Google Scholar 

  28. Kapp, U., et al. (1999). Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189:1939–1945.

    Article  PubMed  CAS  Google Scholar 

  29. Bernhards, J., Fischer, R., Hubner, K., Schwarze, E.-W. and Georgii, A. (1992). Histopathological classification of Hodgkin’s lymphoma. Ann. Oncol. 3:31–33.

    PubMed  Google Scholar 

  30. Georgii, A., Fischer, R., Hubner, K., Schwarze, E.W. and Bernhards, J. (1993). Classification of Hodgkin’s disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial. Leuk. Lymphoma 9:365–370.

    Article  PubMed  CAS  Google Scholar 

  31. Rüdiger, T., et al. (1998). Workshop report on Hodgkin’s disease and related diseases (“grey zone” lymphoma). Ann. Oncol. 9:31–38.

    Article  Google Scholar 

  32. Gatter, K.C. and Warnke, R.A. (2001). Diffuse large B-cell lymphoma, in Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp171–174, IARC, Lyon.

    Google Scholar 

  33. Banks, P.M. and Warnke, R.A. (2001). Mediastinal (thymic) large B-cell lymphoma, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp175–176, IARC, Lyon.

    Google Scholar 

  34. Drexler, H.G., Gignac, S.M., von Wasielewski, R., Werner, M. and Dirks, W.G. (2000). Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 14:1533–1559.

    Article  PubMed  CAS  Google Scholar 

  35. Stein, H., et al. (2000). CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96:3681–3695.

    PubMed  CAS  Google Scholar 

  36. Delsol, G., Ralfkiaer, E., Stein, H., Wright, D. and Jaffe, E.S. (2001). Anaplastic large cell lymphoma, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp230–235, IARC, Lyon.

    Google Scholar 

  37. Herling, M., et al. (2001). Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin’s disease: results with ALK-11 antibody in 327 untreated patients. Leuk. Lymphoma 42:969–979.

    PubMed  CAS  Google Scholar 

  38. Jaffe, E.S. (2001). Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopahology. Mod. Pathol. 14:219–228.

    Article  PubMed  CAS  Google Scholar 

  39. Ralfkiaer, E., Müller-Hermelink, H.K. and Jaffe, E.S. (2001). Peripheral T-cell lymphoma, unspecified, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp227–229, IARC, Lyon.

    Google Scholar 

  40. Davies, T., Morton, C., Miller-Cassman, R., Balk, S. and Kadin, M. (1992). Hodgkin’s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N. Engl. J. Med. 326:1115–1122.

    Article  Google Scholar 

  41. Brousset, P., et al. (1996). Hodgkin’s disease following mycosis fungoides: phenotypic and molecular evidence for different tumour cell clones. J. Clin. Pathol. 49:504–507.

    Article  PubMed  CAS  Google Scholar 

  42. Marafioti, T., et al. (1997). Origin of nodular lymphocyte-predominant Hodgkin’s disease from a clonal expansion of highly mutated germinal-center B cells. N. Engl. J. Med. 337:453–458.

    Article  PubMed  CAS  Google Scholar 

  43. Achten, R., Verhoef, G., Vanuytsel, L. and De Wolf-Peeters, C. (2002). Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 40:31–45.

    Article  PubMed  Google Scholar 

  44. Rüdiger, T., et al. (2002). Workshop on the relationship between nodular lymphocyte predominant Hodgkin’s lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann. Oncol. 13(Suppl. 1):44–51.

    PubMed  Google Scholar 

  45. Jundt, F., et al. (2002). Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 99(8):3060–3062.

    Article  PubMed  CAS  Google Scholar 

  46. Brauninger, A., et al. (1999). MOlecular analysis of single B cells from T-cell rich B-cell lymphoma shows the derivation of the tumour cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood 93:2679–2678.

    PubMed  CAS  Google Scholar 

  47. Krikorian, J.G., Burke, J.S., Rosenberg, S.A. and Kaplan, H.S. (1979). Occurrence of non-Hodgkin’s lymphoma after therapy for Hodgkin’s disease. N. Engl. J. Med. 300:452–458.

    Article  PubMed  CAS  Google Scholar 

  48. Kingma, D.W., et al. (1994). Epstein-Barr virus is infrequently identified in non-Hodgkin’s lymphoma associated with Hodgkin’s disease. Am. J. Surg. Pathol. 18:48–61.

    Article  PubMed  CAS  Google Scholar 

  49. Carrato, A., Filippa, D. and Koziner, B. (1987). Hodgkin’s disease after treatment of non-Hodgkin’s lymphoma. Cancer 60:887–896.

    Article  PubMed  CAS  Google Scholar 

  50. Williams, J., Schned, A., Cotelingam, J.D. and Jaffe, E.S. (1991). Chronic lymphocytic leukemia with coexistent Hodgkin’s disease: implications for the origin of the Reed-Sternberg cell. Am. J. Surg. Pathol. 15:33–42.

    Article  PubMed  CAS  Google Scholar 

  51. Ohno, T., et al. (1998). Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin’s transformation.” Blood 91:1757–1761.

    PubMed  CAS  Google Scholar 

  52. Momose, H., Jaffe, E.S., Shin, S.S., Chen, Y.Y. and Weiss, L.M. (1992). Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg like cells and possible transformation to Hodgkin’s disease: mediation by Epstein-Barr virus. Am. J. Surg. Pathol. 16:859–867.

    Article  PubMed  CAS  Google Scholar 

  53. Richter, M.N. (1928). Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am. J. Pathol. 4:285–292.

    CAS  PubMed  Google Scholar 

  54. O’Sullivan, M.J., Kaleem, Z., Bolger, M.J., Swanson, P.E. and Zutter, M.M. (2000). Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia. Arch. Pathol. Lab. Med. 124(6):907–909.

    PubMed  CAS  Google Scholar 

  55. Giles, F.J., O’Brien, S.M. and Keating, M.J. (1998). Chronic lymphocytic leukemia in (Richter’s) transformation. Semin. Oncol. 25:117.

    PubMed  CAS  Google Scholar 

  56. Gonzales, C.L., Medeiros, L.J. and Jaffe, E.S. (1991). Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin’s disease and B-cell non-Hodgkin’s lymphoma. Am. J. Clin. Pathol. 96:81–89.

    Google Scholar 

  57. van den Bergh, A., et al. (2002). Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood 100(4):1425–1429.

    Google Scholar 

  58. Niedobitek, G., et al. (2000). Hodgkin’s disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection. J. Pathol. 191(4):394–399.

    Article  PubMed  CAS  Google Scholar 

  59. Wlodarska, I., et al. (1993). T-Cell lymphoma developing in Hodgkin’s disease: evidence for two clones. J. Pathol. 170:239–248.

    Article  PubMed  CAS  Google Scholar 

  60. Kremer, M., et al. (2001). Epstein-Barr virus-negative Hodgkin’s lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin. Mod. Pathol. 14:91–97.

    Article  PubMed  CAS  Google Scholar 

  61. Hawkins, K.A., et al. (1983). Simultaneous occurrence of mycosis fungoides and Hodgkin’s disease: clinical and histologic correlations in three cases with ultrastructural studies in two. Am. J. Hematol. 14:355–362.

    Article  PubMed  CAS  Google Scholar 

  62. Bee, C.S., Blaise, Y.P. and Dunphy, C.H. Composite lymphoma of Hodgkin lymphoma and mycosis fungoides: previously underscribed in the same extracutaneous site. Leuk. Lymphoma 42:543–549.

  63. Greene, M.H., et al. (1982). Lymphomas and leukemias in the relatives of patients with mycosis fungoides. Cancer 49:737–741.

    Article  PubMed  CAS  Google Scholar 

  64. Brauninger, A., et al. (1999). Identification of common germinal-center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N. Engl. J. Med. 340:1239–1247.

    Article  PubMed  CAS  Google Scholar 

  65. Küppers, R., et al. (2001). Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin’s disease and either follicular lymphoma or B-CLL. Mol. Med. 7:285–292.

    PubMed  Google Scholar 

  66. Barrios, L., et al. (1988). Chromosomal abnormalities in peripheral blood lymphocytes from untreated Hodgkin’s patients. A possible evidence for genetic instability. Hum. Genet. 78:320–324.

    Article  PubMed  CAS  Google Scholar 

  67. M’kacher, R., et al. (2001). Treatment induced chromocomal aberrations in circulating lymphocytes in patients with Hodgkin’s disease. Leuk. Lymphoma 42:35 (abstract).

    Google Scholar 

  68. Müller-Hermelink, H.K., Zettl, A., Pfeifer, W. and Ott, G. (2001). Pathology of lymphoma progression. Histopathology 38:285–306.

    Article  PubMed  Google Scholar 

  69. Amini, R.-M., et al. (2002). A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leuk. Lymphoma 43:2179–2189.

    Article  PubMed  Google Scholar 

  70. Cazals-Hatem, D., et al. (2001). Pathologic and clinical features of 77 Hodgkin’s lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study. Am. J. Surg. Pathol. 25:297–306.

    Article  PubMed  CAS  Google Scholar 

  71. Enblad, G., Gustafsson, A., Sundström, C. and Glimelius, B. (2002). Elderly patients with Hodgkin lymphoma treated with a new treatment strategy. Acta Oncolo., in press.

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden

    Gunilla Enblad

  2. Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, SE-751 85, Uppsala, Sweden

    Rose-Marie Amini MD, PhD

Authors
  1. Rose-Marie Amini MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunilla Enblad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rose-Marie Amini MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amini, RM., Enblad, G. Relationship between Hodgkin’s and non-Hodgkin’s lymphomas. Med Oncol 20, 211–220 (2003). https://doi.org/10.1385/MO:20:3:211

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/MO:20:3:211

Key Words

Search

Navigation